Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Schneekloth

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Nature Chemical Biology|October 19, 2017
Drug discovery: Controlling protein SUMOylationJohn S Schneekloth
Trends in Pharmacological Sciences|May 25, 2019
Targeting Non-coding RNA Sensitizes Cancer Cells to DrugsMo Yang, John S Schneekloth
Nature Chemistry|September 11, 2023
RNA as an off-target for FDA-approved drugsChristopher R Fullenkamp, John S Schneekloth
Cell Chemical Biology|December 22, 2018
Targeting Mammalian Translational Inhibition with TetracyclinesRobert E Boer, John S Schneekloth
Current Drug Targets|May 13, 2011
Natural product inhibitors of the ubiquitin-proteasome pathwayJohn S Schneekloth, Craig M Crews
Trends in Pharmacological Sciences|February 1, 2022
Heterobifunctional molecules tackle targeted protein dephosphorylationChristopher D Sibley, John S Schneekloth
Chembiochem : a European Journal of Chemical Biology|November 9, 2004
Chemical approaches to controlling intracellular protein degradationJohn S Schneekloth, Craig M Crews
Methods (San Diego, Calif.)|April 26, 2016
Microarray-based technologies for the discovery of selective, RNA-binding moleculesFardokht A Abulwerdi, John S Schneekloth
Current Protocols in Chemical Biology|December 4, 2020
Three-Color Imaging Enables Simultaneous Screening of Multiple RNA Targets on Small Molecule MicroarraysDeondre Jordan, Mo Yang, John S Schneekloth
Chemical Science|July 24, 2013
A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reactionJimin Kim, John S Schneekloth, Erik J Sorensen
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Nature Chemical Biology|October 19, 2017
Drug discovery: Controlling protein SUMOylationJohn S Schneekloth
Trends in Pharmacological Sciences|May 25, 2019
Targeting Non-coding RNA Sensitizes Cancer Cells to DrugsMo Yang, John S Schneekloth
Nature Chemistry|September 11, 2023
RNA as an off-target for FDA-approved drugsChristopher R Fullenkamp, John S Schneekloth
Cell Chemical Biology|December 22, 2018
Targeting Mammalian Translational Inhibition with TetracyclinesRobert E Boer, John S Schneekloth
Current Drug Targets|May 13, 2011
Natural product inhibitors of the ubiquitin-proteasome pathwayJohn S Schneekloth, Craig M Crews
Trends in Pharmacological Sciences|February 1, 2022
Heterobifunctional molecules tackle targeted protein dephosphorylationChristopher D Sibley, John S Schneekloth
Chembiochem : a European Journal of Chemical Biology|November 9, 2004
Chemical approaches to controlling intracellular protein degradationJohn S Schneekloth, Craig M Crews
Methods (San Diego, Calif.)|April 26, 2016
Microarray-based technologies for the discovery of selective, RNA-binding moleculesFardokht A Abulwerdi, John S Schneekloth
Current Protocols in Chemical Biology|December 4, 2020
Three-Color Imaging Enables Simultaneous Screening of Multiple RNA Targets on Small Molecule MicroarraysDeondre Jordan, Mo Yang, John S Schneekloth
Chemical Science|July 24, 2013
A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reactionJimin Kim, John S Schneekloth, Erik J Sorensen
Pageof 10